Diabetes Mellitus
Diabetes Mellitus
Types
Type 1 Diabetes Mellitus/ Juvenile Onset Diabetes mellitus
Type 2 Diabetes Mellitus/ Adult-onset Diabetes Mellitus
Causes
Autoimmune
Secondary causes of Diabetes secondary to other medical conditions
Endocrine causes
Cushing’s syndrome
Acromegaly
Pheochromocytoma
Haemochromatosis
Chronic pancreatitis
PCOS
Medications
Thiazide diuretics
Corticosteroid therapy
High dose estrogen therapy
Others
Gestational diabetes
Risk factors
Age >40
Obesity
People from the Indian subcontinent, Aboriginal and Torres Strait, Chinese
Positive family history of diabetes
Gestational diabetes
Sedentary lifestyle
PCOS
Ischemic heart disease
Hypertension
Medications such as corticosteroids therapy, thiazide diuretics
Clinical features
Tiredness/fatigue
Polyuria
Polydipsia
Weight loss
Increase skin bacterial infections/ fungal infections such as thrush
Other features related to complications of Diabetes and will be discussed later
Diabetes diagnosis
HbA1c ≥6.5% (48 mmol/mol)
Fasting glucose ≥7.0 mmol/L.- Needs 2 readings if asymptomatic
Random glucose ≥11.1 mmol/L.
On a 75 g oral glucose tolerance test: fasting glucose ≥7.0 mmol/L or 2 hr glucose ≥11.1 mmol/L.
Note for fasting glucose levels
If the patient is asymptomatic then at least 2 separate values are required
If the patient is symptomatic such as polydipsia, polyuria, then only one reading is enough
Diabetic groups of medications used to treat Diabetes Mellitus
Biguanides
(metformin)
- blocks glucose release from the liver
- improves insulin sensitivity
- increases the peripheral utilisation of glucose.
Side effects
- nausea
- vomiting
- anorexia
- diarrhoea.
Sulphonylureas
(glibenclamide, gliclazide, glimepiride, glipizide)
- stimulates the pancreas to release more insulin
- may decrease insulin resistance.
Side effects
- hypoglycaemia
- weight gain.
DPP-4 inhibitors
(alogliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin)
- blocks the action of the DPP-4 enzyme
- stimulates the release of insulin
- blocks the release of glucose from the liver.
Side effects
- respiratory tract infections
- common cold symptoms
(sore throat, runny nose, cough) - hypoglycaemia (when used with insulin or a sulphonylurea)
- headaches
- musculoskeletal pain.
SGLT2 inhibitors
(dapagliflozin, empagliflozin, ertugliflozin)
- blocks glucose from being reabsorbed by the kidneys
Side effects
- urinary tract infections
- yeast infections
- dehydration
- constipation
- nausea
- increased thirst
- hypoglycaemia (when used with insulin or a sulphonylurea)
- increased urination or pain on urination.
Thiazolidinediones
(pioglitazone)
- improves the sensitivity of cells to insulin
- decreases glucose release from the liver.
Side effects
- weight gain
- fluid accumulation
- headache
- dizziness
- joint or muscle pain.
Alpha-glucosidase inhibitors
(acarbose)
- slows down the digestion of carbohydrates from food.
Side effects
- flatulence (wind)
- bloating
- diarrhoea
- abdominal pain.
Diabetes injectable preparations
GLP-1 agonists
(dulaglutide, exenatide, liraglutide, semaglutide)
- blocks glucose release from the liver
- slows glucose release from the gut
- stimulates the release of insulin
- decreases appetite.
Side effects
- nausea
- vomiting
- diarrhoea
- constipation
- reflux
- abdominal pain
- fatigue
- injection site reaction
- hypoglycaemia (when used with insulin or a sulphonylurea)
Insulin
- Allows glucose to move from the bloodstream to the body cells
Side effects
- hypoglycaemia
- injection site reaction
- weight gain
Diabetes Complications
Hypertension
Stroke
Ischemic heart disease/ Angina/Myocardial infarction
Diabetic nephropathy
Diabetic cardiomyopathy.
Diabetic peripheral neuropathy
Diabetic retinopathy
Diabetic ketoacidosis
Non ketotic hyperosmolar coma
Foot gangrene/ ulcer/ diabetic foot
Recurrent skin infections- Bacterial /fungal
Peripheral vascular disease
Hypoglycemia
Cataract
Depression (Common with all chronic illnesses and often forgotten in the exam)